NEW YORK — Micronoma, a developer of microbiome-based cancer detection technology, said on Thursday that it has raised $3 million in seed funding in a financing round led by SymBiosis.
Micronoma was spun out of the University of California, San Diego in 2019 to commercialize technology based on the discovery that unique microbial DNA signatures in blood and tissue could distinguish healthy individuals from patients with a variety of cancers.